GWe should have some money from Bayer, so I won't worry about CR for a while.I don't buy Jenny's line that the figure should remain confidential.. This is a public company.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential